Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging
Status:
Not yet recruiting
Trial end date:
2028-08-31
Target enrollment:
Participant gender:
Summary
To learn if an MRSI can be performed on a 3T scanner using an investigational contrast drug
called hyperpolarized 13-C pyruvate. 3T refers to the "strength" of the MRI machine.